Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:10410861rdf:typepubmed:Citationlld:pubmed
pubmed-article:10410861lifeskim:mentionsumls-concept:C0079773lld:lifeskim
pubmed-article:10410861lifeskim:mentionsumls-concept:C0205462lld:lifeskim
pubmed-article:10410861lifeskim:mentionsumls-concept:C0243161lld:lifeskim
pubmed-article:10410861lifeskim:mentionsumls-concept:C0185125lld:lifeskim
pubmed-article:10410861pubmed:issue3lld:pubmed
pubmed-article:10410861pubmed:dateCreated1999-9-21lld:pubmed
pubmed-article:10410861pubmed:abstractTextThe term cutaneous T-cell lymphoma was originally coined to encompass the spectrum of mycosis fungoides and Sézary syndrome. It has become increasingly evident that the histopathologic diagnosis of CTCL can be exceedingly challenging. A series of recent studies, however, have helped clarify the nature of the histologic findings in CTCL. Recently reported histologic data on mycosis fungoides, Sézary syndrome, and their variants is emphasized in this article, with special focus given to the findings in early lesions. A brief summary of lymphocyte immunophenotyping and the role of T-cell reception gene rearrangements in CTCL is included.lld:pubmed
pubmed-article:10410861pubmed:languageenglld:pubmed
pubmed-article:10410861pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10410861pubmed:citationSubsetIMlld:pubmed
pubmed-article:10410861pubmed:statusMEDLINElld:pubmed
pubmed-article:10410861pubmed:monthJullld:pubmed
pubmed-article:10410861pubmed:issn0733-8635lld:pubmed
pubmed-article:10410861pubmed:authorpubmed-author:ShapiroP EPElld:pubmed
pubmed-article:10410861pubmed:authorpubmed-author:McNiffJ MJMlld:pubmed
pubmed-article:10410861pubmed:authorpubmed-author:GlusacE JEJlld:pubmed
pubmed-article:10410861pubmed:issnTypePrintlld:pubmed
pubmed-article:10410861pubmed:volume17lld:pubmed
pubmed-article:10410861pubmed:ownerNLMlld:pubmed
pubmed-article:10410861pubmed:authorsCompleteYlld:pubmed
pubmed-article:10410861pubmed:pagination601-14, ixlld:pubmed
pubmed-article:10410861pubmed:dateRevised2005-11-16lld:pubmed
pubmed-article:10410861pubmed:meshHeadingpubmed-meshheading:10410861...lld:pubmed
pubmed-article:10410861pubmed:meshHeadingpubmed-meshheading:10410861...lld:pubmed
pubmed-article:10410861pubmed:meshHeadingpubmed-meshheading:10410861...lld:pubmed
pubmed-article:10410861pubmed:meshHeadingpubmed-meshheading:10410861...lld:pubmed
pubmed-article:10410861pubmed:meshHeadingpubmed-meshheading:10410861...lld:pubmed
pubmed-article:10410861pubmed:meshHeadingpubmed-meshheading:10410861...lld:pubmed
pubmed-article:10410861pubmed:meshHeadingpubmed-meshheading:10410861...lld:pubmed
pubmed-article:10410861pubmed:meshHeadingpubmed-meshheading:10410861...lld:pubmed
pubmed-article:10410861pubmed:year1999lld:pubmed
pubmed-article:10410861pubmed:articleTitleCutaneous T-cell lymphoma. Refinement in the application of controversial histologic criteria.lld:pubmed
pubmed-article:10410861pubmed:affiliationDepartment of Dermatology, Yale Dermatopathology Laboratory, New Haven, Connecticut, USA.lld:pubmed
pubmed-article:10410861pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:10410861pubmed:publicationTypeReviewlld:pubmed